BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32863293)

  • 21. The presence of SDHB mutations should modify surgical indications for carotid body paragangliomas.
    Ellis RJ; Patel D; Prodanov T; Nilubol N; Pacak K; Kebebew E
    Ann Surg; 2014 Jul; 260(1):158-62. PubMed ID: 24169168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma.
    Hadoux J; Favier J; Scoazec JY; Leboulleux S; Al Ghuzlan A; Caramella C; Déandreis D; Borget I; Loriot C; Chougnet C; Letouzé E; Young J; Amar L; Bertherat J; Libé R; Dumont F; Deschamps F; Schlumberger M; Gimenez-Roqueplo AP; Baudin E
    Int J Cancer; 2014 Dec; 135(11):2711-20. PubMed ID: 24752622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined surgical and radiosurgical treatment for a symptomatic cervical metastasis in a case of malignant paraganglioma: a case report.
    Sasaki K; Inose H; Kawabata S; Yoshii T; Kato T; Saito M; Okawa A
    BMC Res Notes; 2013 Dec; 6():494. PubMed ID: 24289190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: specific implications for succinate dehydrogenase enzyme subunit B gene mutations.
    Zelinka T; Timmers HJ; Kozupa A; Chen CC; Carrasquillo JA; Reynolds JC; Ling A; Eisenhofer G; Lazúrová I; Adams KT; Whatley MA; Widimsky J; Pacak K
    Endocr Relat Cancer; 2008 Mar; 15(1):311-23. PubMed ID: 18310297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-specific prognosis of mutation-positive patients with head and neck paragangliomas.
    Sen I; Young WF; Kasperbauer JL; Polonis K; Harmsen WS; Colglazier JJ; DeMartino RR; Oderich GS; Kalra M; Bower TC
    J Vasc Surg; 2020 May; 71(5):1602-1612.e2. PubMed ID: 32035780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Malignant paraganglioma associated with succinate dehydrogenase subunit B in an 8-year-old child: the age of first screening?
    Prodanov T; Havekes B; Nathanson KL; Adams KT; Pacak K
    Pediatr Nephrol; 2009 Jun; 24(6):1239-42. PubMed ID: 19189136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The genetics of paragangliomas: a review.
    Martin TP; Irving RM; Maher ER
    Clin Otolaryngol; 2007 Feb; 32(1):7-11. PubMed ID: 17298303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes.
    Benn DE; Gimenez-Roqueplo AP; Reilly JR; Bertherat J; Burgess J; Byth K; Croxson M; Dahia PL; Elston M; Gimm O; Henley D; Herman P; Murday V; Niccoli-Sire P; Pasieka JL; Rohmer V; Tucker K; Jeunemaitre X; Marsh DJ; Plouin PF; Robinson BG
    J Clin Endocrinol Metab; 2006 Mar; 91(3):827-36. PubMed ID: 16317055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
    Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG
    Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance and peculiarities of succinate dehydrogenase B and hypoxia inducible factor 1α expression in parasympathetic versus sympathetic paragangliomas.
    Bernardo-Castiñeira C; Sáenz-de-Santa-María I; Valdés N; Astudillo A; Balbín M; Pitiot AS; Jiménez-Fonseca P; Scola B; Tena I; Molina-Garrido MJ; Sevilla MA; Beristein E; Forga L; Villabona C; Oriola J; Halperin I; Suarez C; Chiara MD
    Head Neck; 2019 Jan; 41(1):79-91. PubMed ID: 30549360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positive Immunostaining for Succinate Dehydrogenase B (SDHB) in Paraganglioma Associated with Germline Mutation of SDHB, L157X and P236S.
    Sato H; Inomoto C
    Tokai J Exp Clin Med; 2020 Sep; 45(3):148-151. PubMed ID: 32901905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pediatric patients with pheochromocytoma and paraganglioma should have routine preoperative genetic testing for common susceptibility genes in addition to imaging to detect extra-adrenal and metastatic tumors.
    Babic B; Patel D; Aufforth R; Assadipour Y; Sadowski SM; Quezado M; Nilubol N; Prodanov T; Pacak K; Kebebew E
    Surgery; 2017 Jan; 161(1):220-227. PubMed ID: 27865588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment and outcome of metastatic paraganglioma of the spine.
    Jia Q; Yin H; Yang J; Wu Z; Yan W; Zhou W; Yang X; Xiao J
    Eur Spine J; 2018 Apr; 27(4):859-867. PubMed ID: 28653097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High frequency of germline succinate dehydrogenase mutations in sporadic cervical paragangliomas in northern Spain: mitochondrial succinate dehydrogenase structure-function relationships and clinical-pathological correlations.
    Lima J; Feijão T; Ferreira da Silva A; Pereira-Castro I; Fernandez-Ballester G; Máximo V; Herrero A; Serrano L; Sobrinho-Simões M; Garcia-Rostan G
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4853-64. PubMed ID: 17848412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paraganglioma of the Vagina Associated With Germline SDHB Mutation: Report of a Case With Review of the Literature.
    Wong RW; Liu APY; Choi CKM; Chan AOK
    Int J Gynecol Pathol; 2020 Nov; 39(6):599-604. PubMed ID: 31851064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SDHB mutation status and tumor size but not tumor grade are important predictors of clinical outcome in pheochromocytoma and abdominal paraganglioma.
    Assadipour Y; Sadowski SM; Alimchandani M; Quezado M; Steinberg SM; Nilubol N; Patel D; Prodanov T; Pacak K; Kebebew E
    Surgery; 2017 Jan; 161(1):230-239. PubMed ID: 27839933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neck paraganglioma and follicular lymphoma: a case report.
    Marchetti L; Perrucci L; D'Ercole F; Zatelli MC; Ambrosio MR; Giganti M; Carnevale A
    J Med Case Rep; 2019 Dec; 13(1):376. PubMed ID: 31856921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetics of hereditary head and neck paragangliomas.
    Boedeker CC; Hensen EF; Neumann HP; Maier W; van Nederveen FH; Suárez C; Kunst HP; Rodrigo JP; Takes RP; Pellitteri PK; Rinaldo A; Ferlito A
    Head Neck; 2014 Jun; 36(6):907-16. PubMed ID: 23913591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypic variability and risk of malignancy in SDHC-linked paragangliomas: lessons from three unrelated cases with an identical germline mutation (p.Arg133*).
    Bickmann JK; Sollfrank S; Schad A; Musholt TJ; Springer E; Miederer M; Bartsch O; Papaspyrou K; Koutsimpelas D; Mann WJ; Weber MM; Lackner KJ; Rossmann H; Fottner C
    J Clin Endocrinol Metab; 2014 Mar; 99(3):E489-96. PubMed ID: 24423348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of succinate dehydrogenase-deficient bladder paragangliomas.
    Mason EF; Sadow PM; Wagner AJ; Remillard SP; Flood TA; Belanger EC; Hornick JL; Barletta JA
    Am J Surg Pathol; 2013 Oct; 37(10):1612-8. PubMed ID: 23797725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.